The University of Arizona Genetics Core for Clinical Services Laboratory (UAGC-CS)
UAGC-CS is a CLIA certified/CAP accredited laboratory specializing in clinical molecular genetic testing.
Chimerism testing for engraftment analysis identifies the extent of mixture in the recipient’s blood or bone marrow after a hematopoietic stem cell transplantLearn More
Solid Tumor Testing
This assay can detect single nucleotide variants (SNVs) and small insertions/deletions that are targets for cancer therapeutic or prognosis. It covers hotspots, full exons or the entire gene within 26 of the most relevant cancer genes involved in solid tumors. It can be performed on even on the most challenging FFPE samples.Learn More
This is an assay that assesses the risk of distant recurrence of disease in patients with breast cancer. It utilizes a qualitative gene expression data, weighted together with clinical variables to generate a risk category and numerical score called Risk Of Recurrence (ROR). This score is used to assess a patient’s risk of distant recurrence of disease. This assay is performed on breast tumor tissues previously diagnosed as invasive breast carcinoma and are fixed in formalin and embedded in paraffin.Learn More
CES is a test that examines the portion of the genome that encodes for proteins (exons) and their flanking splice junctions. CES aims to identify disease-causing variants within the exons. CES interprets the identified variants within the context of the clinical presentation in order to reach a diagnosis for patients with challenging undiagnosed genetic disorders.Learn More